about
Prone imaging allows efficient radiopharmaceutical usage by obviating the necessity of a rest study in Tc-99m-methoxyisobutylisonitrile myocardial perfusion scintigraphy.Prostate-specific antigen decline pattern in advanced prostate cancer receiving androgen deprivation therapy and relationship with prostate-specific antigen progression.The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.Epitrochlear and axillary lymph node visualization on FDG-PET/CT imaging in a patient with rheumatoid arthritis.Intramedullary metastasis detected with 18F FDG-PET/CT.The value of FDG-PET/CT in the post-treatment evaluation of endometrial carcinoma: a comparison of PET/CT findings with conventional imaging and CA 125 as a tumour marker.Primary epithelioid trophoblastic tumor with a synchronous breast carcinoma detected only with FDG-PET/CT Scan.Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.Bone and peritoneal metastasis of breast carcinoma: findings on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.The Role of F-FDG PET/CT in Detecting Ovarian Cancer Recurrence in Patients with Elevated CA-125 LevelsSplenosis Mimicking Lymphoma Relapse Confirmed by 18 F-FDG PET/CT and Tc-99m Nano-colloid Scintigraphy Thirty Years After Splenectomy for TraumaMcCune-Albright syndrome associated with acromegaly and bipolar affective disorderAn interesting contamination artifact appearing in I-(131) whole-body imaging after ablative therapyAmyloidosis Associated Kidney Failure with Gross Hypermetabolic Intra-abdominal MassMinimal Invasive Radioguided Ectopic Parathyroidectomy in Upper MediastinumLymphoblastic Involvement of the Bone Marrow as a Cause of Superscan Appearance in 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
P50
Q46476791-8EE68711-4051-4CBD-8711-49DA54429003Q48115202-B8F3B998-C9E4-4995-BEC3-E0E6F2F5141DQ51532371-31148506-B09B-4484-AD91-175DA76326D3Q51558124-FD5B7747-6A83-47F7-9A53-B1229C3DCAE5Q53136868-BDA64768-79EC-48B0-8E95-DA360280C5FEQ53136890-9EB78F1A-DA44-4792-B9FB-0FD66D2B5E24Q53235532-B0961D2A-47F8-400F-A93C-E4C70351198BQ53242841-82AD8E9B-4DEB-4163-BFBF-5E35905229B9Q53243390-15A958C8-DFFB-4288-A256-5FE26E6B6F5EQ53472459-96660DDE-3EA7-4D40-8576-FC5EFC7FCAA4Q64077005-7287E49A-5BE0-4F28-8524-F1F4F7FA442CQ64077013-2DCFB597-3529-4265-966F-1EB9F18298BCQ80135471-54B48E7C-D40C-43BA-8ED4-86EDD3F09E63Q83144314-98F135F9-59CA-4D22-8A90-5CB08560EA88Q89806411-C382BECB-76F5-4187-B887-AC48F6C32ED5Q90048720-FEF614F0-3D82-4C1D-8541-0B805F4DA066Q94529528-DA2FDAB4-F359-4F18-ABE5-521EA03917A2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pelin Ozcan Kara
@ast
Pelin Ozcan Kara
@en
Pelin Ozcan Kara
@es
Pelin Ozcan Kara
@nl
Pelin Ozcan Kara
@sl
type
label
Pelin Ozcan Kara
@ast
Pelin Ozcan Kara
@en
Pelin Ozcan Kara
@es
Pelin Ozcan Kara
@nl
Pelin Ozcan Kara
@sl
prefLabel
Pelin Ozcan Kara
@ast
Pelin Ozcan Kara
@en
Pelin Ozcan Kara
@es
Pelin Ozcan Kara
@nl
Pelin Ozcan Kara
@sl
P1053
I-7395-2017
P106
P1153
36091704500
P31
P3829
P496
0000-0003-0147-2678